For instance, miR‐133a was found to be a tumor suppressive miRNA to inhibit HCC progression through targeting Fos‐related antigen 2 (601575)/transforming growth factor‐β/SMAD family member 3 (603109) signaling pathway (Sun et al., 2018). Here, SMAD3 is linked to neoplasm.